GMO Beyond China ETF (BCHI) Hits New 52-Week High Amid Supply Chain Diversification Trends

Monday, Apr 7, 2025 9:46 am ET1min read

The GMO Beyond China ETF (BCHI.P) is an equity ETF focused on delivering total returns by investing primarily in companies poised to benefit from the trend of diversifying supply chains away from China. With an expense ratio of 0.65% and a leverage ratio of 1.0, this ETF is categorized under active equity ETFs. Despite some recent outflows, the ETF has seen significant trading activity, indicating a robust interest in its underlying investment theme.



The GMO Beyond China ETF reached a new 52-week high, which reflects increasing investor confidence and potentially favorable market conditions. However, it is important to note that the ETF experienced notable outflows recently, with net fund flows reflecting a decrease across various order sizes.


On the technical front, the ETF's relative strength index (RSI) is currently indicating an oversold condition, which could imply that the ETF is poised for a corrective bounce or rally after reaching its 52-week high. No significant signals such as golden or dead crosses have been detected, which suggests a neutral technical outlook despite the recent price movements.


ETF CodeExpense Ratio Leverage RatioAUM
CEMB.B0.51.0$392M
CALI.O0.21.0$68M
BKHY.P0.221.0$350M
BSMV.O0.181.0$100M
CLOZ.P0.51.0$763M
BSCX.O0.11.0$545M
BSJU.O0.421.0$109M
APMU.P0.371.0$164M
BND.P0.031.0$129B
BSCU.O0.11.0$2B

Investors in the GMO Beyond China ETF face opportunities as the ETF benefits from a growing trend of supply chain diversification. However, the recent outflows and the technical oversold condition present challenges that may require cautious monitoring. Balancing these factors will be crucial for investors looking to capitalize on the ETF's potential.


Expert analysis and key market insights keeping you informed on latest trends and opportunities in ETF's.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



No comments

No comments yet